Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurosurgical Procedures | 25 | 2022 | 140 | 5.930 |
Why?
|
| Brain Neoplasms | 18 | 2021 | 90 | 5.690 |
Why?
|
| Epilepsy | 10 | 2018 | 68 | 2.980 |
Why?
|
| Epilepsy, Temporal Lobe | 8 | 2021 | 29 | 2.520 |
Why?
|
| Temporal Lobe | 8 | 2021 | 63 | 2.040 |
Why?
|
| Pituitary Neoplasms | 3 | 2023 | 17 | 1.970 |
Why?
|
| Glioma | 6 | 2021 | 23 | 1.840 |
Why?
|
| Meningioma | 5 | 2020 | 15 | 1.800 |
Why?
|
| Neurosurgery | 7 | 2023 | 39 | 1.610 |
Why?
|
| Magnetic Resonance Imaging | 22 | 2023 | 880 | 1.410 |
Why?
|
| Humans | 65 | 2023 | 23355 | 1.350 |
Why?
|
| Meningeal Neoplasms | 2 | 2020 | 13 | 1.270 |
Why?
|
| Brain Mapping | 3 | 2021 | 123 | 1.270 |
Why?
|
| Adenoma | 2 | 2023 | 61 | 1.240 |
Why?
|
| Electric Stimulation | 3 | 2019 | 49 | 1.210 |
Why?
|
| Adult | 32 | 2021 | 7078 | 1.190 |
Why?
|
| Treatment Outcome | 21 | 2023 | 2989 | 1.150 |
Why?
|
| Female | 40 | 2021 | 13149 | 1.150 |
Why?
|
| Postoperative Complications | 9 | 2016 | 836 | 1.130 |
Why?
|
| Hippocampus | 6 | 2021 | 200 | 1.130 |
Why?
|
| Glioblastoma | 3 | 2021 | 12 | 1.120 |
Why?
|
| Male | 40 | 2021 | 12655 | 1.060 |
Why?
|
| Craniotomy | 4 | 2020 | 21 | 1.010 |
Why?
|
| Electroencephalography | 8 | 2016 | 78 | 1.010 |
Why?
|
| Middle Aged | 28 | 2021 | 8072 | 1.010 |
Why?
|
| Electrodes, Implanted | 2 | 2015 | 22 | 0.880 |
Why?
|
| Ganglioglioma | 3 | 2015 | 6 | 0.880 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2013 | 9 | 0.870 |
Why?
|
| Deep Brain Stimulation | 4 | 2021 | 40 | 0.800 |
Why?
|
| Lumbar Vertebrae | 3 | 2018 | 357 | 0.790 |
Why?
|
| Endoscopy | 3 | 2023 | 169 | 0.780 |
Why?
|
| Monitoring, Intraoperative | 2 | 2022 | 36 | 0.750 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2022 | 8 | 0.750 |
Why?
|
| Adolescent | 13 | 2021 | 1917 | 0.700 |
Why?
|
| Implantable Neurostimulators | 3 | 2017 | 8 | 0.690 |
Why?
|
| Internship and Residency | 4 | 2021 | 205 | 0.680 |
Why?
|
| Monitoring, Physiologic | 2 | 2014 | 68 | 0.680 |
Why?
|
| Empty Sella Syndrome | 1 | 2020 | 4 | 0.670 |
Why?
|
| Sphenoid Bone | 2 | 2020 | 5 | 0.670 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 127 | 0.660 |
Why?
|
| Young Adult | 11 | 2021 | 1676 | 0.660 |
Why?
|
| Retrospective Studies | 14 | 2021 | 3040 | 0.640 |
Why?
|
| Sclerosis | 3 | 2017 | 56 | 0.620 |
Why?
|
| Emergency Medical Services | 2 | 2011 | 32 | 0.620 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 203 | 0.610 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 59 | 0.610 |
Why?
|
| Superior Sagittal Sinus | 1 | 2019 | 2 | 0.610 |
Why?
|
| Hydrocephalus | 2 | 2021 | 16 | 0.600 |
Why?
|
| Epilepsy, Complex Partial | 3 | 2017 | 5 | 0.590 |
Why?
|
| Incidental Findings | 1 | 2018 | 12 | 0.560 |
Why?
|
| Dura Mater | 1 | 2018 | 16 | 0.560 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 104 | 0.520 |
Why?
|
| Brain Waves | 1 | 2016 | 5 | 0.520 |
Why?
|
| Aged | 13 | 2021 | 7562 | 0.510 |
Why?
|
| Learning Curve | 1 | 2016 | 15 | 0.500 |
Why?
|
| Nasal Cavity | 1 | 2016 | 32 | 0.490 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 322 | 0.490 |
Why?
|
| Cranial Fossa, Middle | 2 | 2019 | 4 | 0.480 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 2 | 0.480 |
Why?
|
| Encephalocele | 2 | 2019 | 21 | 0.480 |
Why?
|
| Amygdala | 3 | 2014 | 37 | 0.470 |
Why?
|
| Subdural Space | 1 | 2015 | 2 | 0.460 |
Why?
|
| Astrocytoma | 3 | 2011 | 18 | 0.460 |
Why?
|
| Paralysis | 1 | 2015 | 14 | 0.460 |
Why?
|
| Neoplasm Grading | 4 | 2019 | 53 | 0.460 |
Why?
|
| Scalp | 1 | 2015 | 6 | 0.460 |
Why?
|
| Humeral Fractures | 1 | 2015 | 20 | 0.450 |
Why?
|
| Boxing | 1 | 2014 | 2 | 0.450 |
Why?
|
| Hematoma, Subdural, Spinal | 1 | 2014 | 3 | 0.450 |
Why?
|
| Lymphoma | 1 | 2015 | 36 | 0.450 |
Why?
|
| Cysts | 1 | 2014 | 14 | 0.440 |
Why?
|
| Essential Tremor | 1 | 2014 | 4 | 0.440 |
Why?
|
| Neurilemmoma | 1 | 2014 | 13 | 0.440 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 12 | 0.430 |
Why?
|
| Professional Competence | 1 | 2014 | 38 | 0.430 |
Why?
|
| Clinical Competence | 1 | 2016 | 204 | 0.430 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 2 | 0.420 |
Why?
|
| Cerebellopontine Angle | 1 | 2014 | 3 | 0.420 |
Why?
|
| Spinal Neoplasms | 1 | 2014 | 35 | 0.420 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 7 | 0.420 |
Why?
|
| General Surgery | 1 | 2014 | 52 | 0.420 |
Why?
|
| Respiration Disorders | 1 | 2013 | 4 | 0.420 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2013 | 5 | 0.420 |
Why?
|
| Syncope | 1 | 2013 | 5 | 0.410 |
Why?
|
| Anticoagulants | 1 | 2014 | 85 | 0.410 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 3785 | 0.400 |
Why?
|
| Panic Disorder | 1 | 2013 | 134 | 0.390 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 1441 | 0.380 |
Why?
|
| Lasers, Gas | 1 | 2012 | 1 | 0.370 |
Why?
|
| Cotton Fiber | 1 | 2012 | 1 | 0.370 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 3 | 0.370 |
Why?
|
| Corpus Callosum | 1 | 2012 | 11 | 0.370 |
Why?
|
| Headache | 2 | 2011 | 38 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 593 | 0.360 |
Why?
|
| Child, Preschool | 4 | 2016 | 578 | 0.360 |
Why?
|
| Gliosarcoma | 1 | 2011 | 2 | 0.350 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 11 | 0.350 |
Why?
|
| Oligodendroglioma | 1 | 2011 | 5 | 0.350 |
Why?
|
| Functional Laterality | 4 | 2018 | 56 | 0.350 |
Why?
|
| Parietal Lobe | 2 | 2014 | 10 | 0.350 |
Why?
|
| Radiosurgery | 3 | 2019 | 32 | 0.340 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 14 | 0.340 |
Why?
|
| Optic Nerve | 2 | 2020 | 7 | 0.340 |
Why?
|
| Manikins | 1 | 2010 | 3 | 0.340 |
Why?
|
| Patient Simulation | 1 | 2010 | 11 | 0.340 |
Why?
|
| Seizures | 5 | 2018 | 67 | 0.330 |
Why?
|
| Neurosurgeons | 3 | 2021 | 9 | 0.330 |
Why?
|
| Brain | 6 | 2017 | 1200 | 0.320 |
Why?
|
| Prognosis | 3 | 2021 | 740 | 0.320 |
Why?
|
| Movement Disorders | 1 | 2010 | 58 | 0.320 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2019 | 18 | 0.320 |
Why?
|
| Preoperative Care | 3 | 2017 | 112 | 0.320 |
Why?
|
| Physicians | 1 | 2011 | 106 | 0.310 |
Why?
|
| Critical Care | 1 | 2010 | 110 | 0.310 |
Why?
|
| Spinal Diseases | 1 | 2010 | 108 | 0.300 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2008 | 4 | 0.290 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 11 | 0.290 |
Why?
|
| Collagen | 1 | 2008 | 81 | 0.280 |
Why?
|
| Geography | 1 | 2008 | 17 | 0.280 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 6 | 0.280 |
Why?
|
| Patient Transfer | 1 | 2008 | 25 | 0.280 |
Why?
|
| Epidural Space | 1 | 2008 | 20 | 0.280 |
Why?
|
| White Matter | 2 | 2021 | 109 | 0.270 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 123 | 0.260 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 99 | 0.260 |
Why?
|
| Child | 4 | 2016 | 1171 | 0.250 |
Why?
|
| Cranial Sinuses | 1 | 2005 | 2 | 0.240 |
Why?
|
| Wounds, Penetrating | 1 | 2005 | 6 | 0.240 |
Why?
|
| Neurologic Examination | 3 | 2014 | 84 | 0.230 |
Why?
|
| Munchausen Syndrome | 1 | 2004 | 1 | 0.230 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2015 | 6 | 0.220 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 339 | 0.210 |
Why?
|
| Allostasis | 1 | 2023 | 4 | 0.210 |
Why?
|
| Chronic Disease | 3 | 2015 | 389 | 0.210 |
Why?
|
| Radiography | 2 | 2015 | 536 | 0.190 |
Why?
|
| Radiotherapy | 2 | 2021 | 32 | 0.190 |
Why?
|
| Evoked Potentials, Motor | 1 | 2022 | 10 | 0.190 |
Why?
|
| Electromyography | 1 | 2022 | 68 | 0.180 |
Why?
|
| Age Factors | 2 | 2021 | 641 | 0.180 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 8 | 0.170 |
Why?
|
| Laparotomy | 1 | 2021 | 17 | 0.170 |
Why?
|
| Karnofsky Performance Status | 1 | 2021 | 3 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2021 | 1429 | 0.170 |
Why?
|
| Drug Therapy | 1 | 2021 | 6 | 0.170 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 11 | 0.170 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 27 | 0.170 |
Why?
|
| Optic Chiasm | 1 | 2020 | 3 | 0.170 |
Why?
|
| Skull | 2 | 2015 | 19 | 0.170 |
Why?
|
| Skull Base | 1 | 2020 | 31 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 169 | 0.170 |
Why?
|
| Survival Analysis | 1 | 2021 | 245 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 108 | 0.160 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 296 | 0.160 |
Why?
|
| Sella Turcica | 1 | 2019 | 4 | 0.160 |
Why?
|
| Surgical Wound | 1 | 2019 | 9 | 0.160 |
Why?
|
| Neuroimaging | 2 | 2018 | 102 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 29 | 0.150 |
Why?
|
| Semicircular Canals | 1 | 2019 | 3 | 0.150 |
Why?
|
| Temporal Bone | 1 | 2019 | 6 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2021 | 314 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2021 | 183 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1050 | 0.150 |
Why?
|
| Wound Healing | 1 | 2019 | 114 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 198 | 0.150 |
Why?
|
| United States | 4 | 2021 | 1829 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 6 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 9 | 0.140 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 11 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 43 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 39 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2018 | 17 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 35 | 0.140 |
Why?
|
| Hand | 1 | 2018 | 39 | 0.140 |
Why?
|
| Laminectomy | 1 | 2018 | 42 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 26 | 0.130 |
Why?
|
| Epilepsies, Partial | 1 | 2017 | 12 | 0.130 |
Why?
|
| Models, Neurological | 1 | 2017 | 21 | 0.130 |
Why?
|
| Orbital Cellulitis | 1 | 2016 | 1 | 0.130 |
Why?
|
| Empyema, Subdural | 1 | 2016 | 2 | 0.130 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 22 | 0.130 |
Why?
|
| Hypopituitarism | 1 | 2016 | 1 | 0.130 |
Why?
|
| Diabetes Insipidus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Visual Fields | 1 | 2016 | 3 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 13 | 0.120 |
Why?
|
| Ependymoma | 1 | 2015 | 17 | 0.120 |
Why?
|
| Sleep Apnea, Central | 1 | 2015 | 30 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 11 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 22 | 0.110 |
Why?
|
| Drainage | 1 | 2015 | 41 | 0.110 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 12 | 0.110 |
Why?
|
| Rivaroxaban | 1 | 2014 | 6 | 0.110 |
Why?
|
| Dabigatran | 1 | 2014 | 6 | 0.110 |
Why?
|
| Antidotes | 1 | 2014 | 4 | 0.110 |
Why?
|
| Pyridones | 1 | 2014 | 10 | 0.110 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 18 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 6 | 0.110 |
Why?
|
| Occipital Lobe | 1 | 2014 | 4 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 305 | 0.110 |
Why?
|
| Head | 1 | 2014 | 18 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 79 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2014 | 53 | 0.110 |
Why?
|
| Mutation | 1 | 2015 | 328 | 0.110 |
Why?
|
| Dominance, Cerebral | 1 | 2013 | 15 | 0.100 |
Why?
|
| Cough | 1 | 2013 | 9 | 0.100 |
Why?
|
| Biopsy | 1 | 2014 | 193 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2014 | 59 | 0.100 |
Why?
|
| Aquaporin 4 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2014 | 129 | 0.100 |
Why?
|
| Neuromyelitis Optica | 1 | 2012 | 2 | 0.100 |
Why?
|
| Aquaporins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 9 | 0.100 |
Why?
|
| Cervical Vertebrae | 2 | 2013 | 274 | 0.100 |
Why?
|
| Disease Progression | 1 | 2014 | 525 | 0.090 |
Why?
|
| Granuloma, Giant Cell | 1 | 2012 | 1 | 0.090 |
Why?
|
| Suction | 1 | 2012 | 33 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 140 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2011 | 24 | 0.090 |
Why?
|
| Brain Edema | 1 | 2011 | 18 | 0.090 |
Why?
|
| Spinal Fusion | 1 | 2018 | 430 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2011 | 14 | 0.090 |
Why?
|
| Age of Onset | 1 | 2011 | 73 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2011 | 52 | 0.080 |
Why?
|
| Acute Disease | 1 | 2011 | 169 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2010 | 23 | 0.080 |
Why?
|
| Gliosis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 124 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 49 | 0.080 |
Why?
|
| Education, Medical | 1 | 2010 | 44 | 0.080 |
Why?
|
| Learning | 1 | 2010 | 62 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 270 | 0.080 |
Why?
|
| Educational Status | 1 | 2011 | 214 | 0.080 |
Why?
|
| Students, Medical | 1 | 2010 | 53 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 71 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 72 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 73 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 1307 | 0.080 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2008 | 2 | 0.070 |
Why?
|
| Blood Patch, Epidural | 1 | 2008 | 7 | 0.070 |
Why?
|
| Subdural Effusion | 1 | 2008 | 7 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 774 | 0.070 |
Why?
|
| Electrodes | 1 | 2008 | 14 | 0.070 |
Why?
|
| Midwestern United States | 1 | 2008 | 47 | 0.070 |
Why?
|
| Pinealoma | 1 | 2007 | 1 | 0.070 |
Why?
|
| Pineal Gland | 1 | 2007 | 4 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 24 | 0.070 |
Why?
|
| Syringomyelia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Stroke | 1 | 2010 | 240 | 0.070 |
Why?
|
| Shoulder Pain | 1 | 2007 | 49 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 1039 | 0.060 |
Why?
|
| Construction Materials | 1 | 2005 | 2 | 0.060 |
Why?
|
| Fascia | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2003 | 112 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 51 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2008 | 1524 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 13 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2002 | 80 | 0.050 |
Why?
|
| Gene Expression | 1 | 2002 | 180 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 16 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 36 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 15 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 431 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 12 | 0.040 |
Why?
|
| Curriculum | 1 | 2020 | 132 | 0.040 |
Why?
|
| Animals | 2 | 2018 | 3301 | 0.040 |
Why?
|
| Smoking | 1 | 2019 | 168 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 25 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 293 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 82 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 176 | 0.030 |
Why?
|
| Neuronavigation | 1 | 2017 | 4 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2017 | 15 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 41 | 0.030 |
Why?
|
| Exophthalmos | 1 | 2016 | 1 | 0.030 |
Why?
|
| Streptococcus milleri Group | 1 | 2016 | 1 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 384 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 48 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 76 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 521 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 50 | 0.030 |
Why?
|
| Sinusitis | 1 | 2016 | 152 | 0.030 |
Why?
|
| Medical Errors | 1 | 2014 | 27 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 363 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 254 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 243 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2012 | 6 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2012 | 7 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 4 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 61 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 149 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 188 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 70 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 168 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 173 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 481 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 1098 | 0.020 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 5 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 1241 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 866 | 0.020 |
Why?
|
| Diplopia | 1 | 2007 | 3 | 0.020 |
Why?
|
| Nystagmus, Pathologic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 272 | 0.020 |
Why?
|
| Football | 1 | 2007 | 21 | 0.020 |
Why?
|
| Baseball | 1 | 2007 | 91 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 56 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 7 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 132 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 258 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 482 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 236 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 314 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 404 | 0.010 |
Why?
|